Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development
Sign Up to like & getrecommendations! Published in 2021 at "Antiviral Research"
DOI: 10.1016/j.antiviral.2021.105020
Abstract: The 3-chymotrypsin-like cysteine protease (3CLpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a major target for the discovery of direct antiviral agents. We previously reported the evaluation of SARS-CoV-2 3CLpro inhibitors in… read more here.
Keywords: protease; inhibition; hrv3c; protease inhibitors ... See more keywords